이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Thermo Fisher Scientific 미래 성장
Future 기준 확인 1/6
Thermo Fisher Scientific (는) 각각 연간 10.6% 및 5.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 11.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 17.7% 로 예상됩니다.
주요 정보
10.6%
수익 성장률
11.3%
EPS 성장률
| Life Sciences 수익 성장 | 16.2% |
| 매출 성장률 | 5.5% |
| 향후 자기자본 수익률 | 17.7% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 27 Jun 2024 |
최근 미래 성장 업데이트
Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 27
Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results
Feb 02Recent updates
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Jun 18Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends
Jun 07Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)
Apr 30Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 27Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching
Apr 24Thermo Fisher Scientific: Too Hot To Handle
Apr 15Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)
Apr 02We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Thermo Fisher's Bright Future Makes It A Great Buy On Weakness
Feb 06Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results
Feb 02Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics
Jan 16Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'
Jan 06Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?
Dec 29Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Dec 11Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.
Dec 02Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07My Family Is Buying A Lot More Thermo Fisher Stock
Oct 31Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness
Sep 28Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Sep 10Thermo Fisher Scientific: A High-Quality Investment For Double-Digit Returns
Aug 28Thermo Fisher: Cash Flow Returns On Investments Analysis
Aug 14Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Jul 25Thermo Fisher Scientific: Continuing To Add To The Fortress
Jul 09수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 49,523 | 8,048 | 8,851 | 10,451 | 19 |
| 12/31/2025 | 46,078 | 6,962 | 8,004 | 9,351 | 25 |
| 12/31/2024 | 43,011 | 6,184 | 7,307 | 8,641 | 25 |
| 3/30/2024 | 42,492 | 6,034 | 7,560 | 8,928 | N/A |
| 12/31/2023 | 42,857 | 5,995 | 6,927 | 8,406 | N/A |
| 9/30/2023 | 43,421 | 5,941 | 6,546 | 8,170 | N/A |
| 7/1/2023 | 43,524 | 5,721 | 5,854 | 7,693 | N/A |
| 4/1/2023 | 43,807 | 6,024 | 5,620 | 7,681 | N/A |
| 12/31/2022 | 44,915 | 6,950 | 6,911 | 9,154 | N/A |
| 10/1/2022 | 44,167 | 7,032 | 5,600 | 8,124 | N/A |
| 7/2/2022 | 42,820 | 7,439 | 6,336 | 8,837 | N/A |
| 4/2/2022 | 41,123 | 7,603 | 7,001 | 9,536 | N/A |
| 12/31/2021 | 39,211 | 7,725 | 6,789 | 9,312 | N/A |
| 10/2/2021 | 39,059 | 8,565 | 7,916 | 10,194 | N/A |
| 7/3/2021 | 38,250 | 8,596 | 8,132 | 10,252 | N/A |
| 4/3/2021 | 35,894 | 7,924 | 8,062 | 9,911 | N/A |
| 12/31/2020 | 32,218 | 6,375 | 6,815 | 8,289 | N/A |
| 9/26/2020 | 28,497 | 4,879 | 5,686 | 6,863 | N/A |
| 6/27/2020 | 26,248 | 3,706 | 4,245 | 5,272 | N/A |
| 3/28/2020 | 25,647 | 3,669 | 3,702 | 4,680 | N/A |
| 12/31/2019 | 25,542 | 3,696 | 4,047 | 4,973 | N/A |
| 9/28/2019 | 25,220 | 3,592 | 3,940 | 4,861 | N/A |
| 6/29/2019 | 24,868 | 3,541 | 4,086 | 4,964 | N/A |
| 3/30/2019 | 24,630 | 3,174 | 4,273 | 5,114 | N/A |
| 12/31/2018 | 24,358 | 2,938 | 3,785 | 4,543 | N/A |
| 9/29/2018 | 23,898 | 2,570 | 3,919 | 4,608 | N/A |
| 6/30/2018 | 23,094 | 2,395 | 3,689 | 4,317 | N/A |
| 3/31/2018 | 22,006 | 2,256 | 3,189 | 3,722 | N/A |
| 12/31/2017 | 20,918 | 2,228 | N/A | 4,005 | N/A |
| 9/30/2017 | 19,824 | 2,330 | N/A | 3,344 | N/A |
| 7/1/2017 | 19,199 | 2,270 | N/A | 3,220 | N/A |
| 4/1/2017 | 18,744 | 2,174 | N/A | 3,284 | N/A |
| 12/31/2016 | 18,274 | 2,025 | N/A | 3,258 | N/A |
| 10/1/2016 | 17,973 | 1,999 | N/A | 3,281 | N/A |
| 7/2/2016 | 17,606 | 2,003 | N/A | 3,220 | N/A |
| 4/2/2016 | 17,341 | 1,998 | N/A | 3,072 | N/A |
| 12/31/2015 | 16,965 | 1,980 | N/A | 2,942 | N/A |
| 9/26/2015 | 16,806 | 1,978 | N/A | 2,543 | N/A |
| 6/27/2015 | 16,854 | 1,971 | N/A | 2,475 | N/A |
| 3/28/2015 | 16,905 | 1,738 | N/A | 2,598 | N/A |
| 12/31/2014 | 16,890 | 1,896 | N/A | 2,620 | N/A |
| 9/27/2014 | 15,864 | 1,635 | N/A | 2,394 | N/A |
| 6/28/2014 | 14,884 | 1,482 | N/A | 2,224 | N/A |
| 3/29/2014 | 13,802 | 1,481 | N/A | 1,814 | N/A |
| 12/31/2013 | 13,090 | 1,279 | N/A | 2,011 | N/A |
| 9/28/2013 | 12,883 | 1,322 | N/A | 1,942 | N/A |
| 6/29/2013 | 12,777 | 1,304 | N/A | 1,917 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: TMO 의 연간 예상 수익 증가율( 10.6% )이 saving rate( 2.4% 보다 높습니다. ).
수익 vs 시장: TMO 의 연간 수익( 10.6% ) US 시장( 14.9% 보다 느리게 성장할 것으로 예상됩니다. 14.9% 연간).
고성장 수익: TMO 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: TMO 의 수익(연간 5.6% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).
고성장 수익: TMO 의 수익(연간 5.6% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: TMO 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 17.7 %).